• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[胃肠胰神经内分泌肿瘤——异质性、管理以及治疗与研究的前景]

[Gastroenteropancreatic neuroendocrine neoplasms-Heterogeneity, management and perspectives of treatment and research].

作者信息

Luley K, Gebauer J, Gebauer N, Tharun L, Buchmann I, Barkhausen J, von Bubnoff N, Lindner K, Keck T, Lehnert H, Schmid S M

机构信息

Klinik für Hämatologie und Onkologie, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Deutschland.

Med. Klinik 1, Abteilung für Endokrinologie, Diabetologie und Stoffwechselmedizin, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Deutschland.

出版信息

Internist (Berl). 2020 Aug;61(8):875-890. doi: 10.1007/s00108-020-00832-x.

DOI:10.1007/s00108-020-00832-x
PMID:32676723
Abstract

The term neuroendocrine neoplasms (NEN) encompasses a molecularly and biologically very heterogeneous group of tumors, which have in common their origin in neuroendocrine cells. The also very heterogeneous subgroup of gastroenteropancreatic neuroendocrine neoplasms (GEP-NEN) is the best classified and investigated group. This article provides a systematic review of the current classification, diagnostics and treatment options of GEP-NEN. In order to achieve a better overview, it was consciously decided not to use an approach based on the primary localization. Instead, a thematic organization according to classification, clinical phenotype, diagnostics and treatment was chosen.

摘要

神经内分泌肿瘤(NEN)这一术语涵盖了一组在分子和生物学上非常异质性的肿瘤,它们的共同之处在于起源于神经内分泌细胞。胃肠胰神经内分泌肿瘤(GEP-NEN)这一同样非常异质性的亚组是分类和研究得最好的组。本文对GEP-NEN的当前分类、诊断和治疗选择进行了系统综述。为了获得更好的概述,特意决定不采用基于原发部位的方法。相反,选择了根据分类、临床表型、诊断和治疗进行主题组织的方式。

相似文献

1
[Gastroenteropancreatic neuroendocrine neoplasms-Heterogeneity, management and perspectives of treatment and research].[胃肠胰神经内分泌肿瘤——异质性、管理以及治疗与研究的前景]
Internist (Berl). 2020 Aug;61(8):875-890. doi: 10.1007/s00108-020-00832-x.
2
Treatment of Gastroenteropancreatic Neuroendocrine Tumors.胃肠胰神经内分泌肿瘤的治疗
Surg Pathol Clin. 2019 Dec;12(4):1045-1053. doi: 10.1016/j.path.2019.08.011.
3
Gastroenteropancreatic neuroendocrine neoplasms: a 10-year experience of a single center.胃肠胰神经内分泌肿瘤:单中心10年经验
Pol Arch Med Wewn. 2015;125(5):337-46. doi: 10.20452/pamw.2832. Epub 2015 Apr 29.
4
Update in the management of gastroenteropancreatic neuroendocrine tumors.胃肠胰神经内分泌肿瘤治疗进展。
Cancer. 2024 Sep 15;130(18):3090-3105. doi: 10.1002/cncr.35463. Epub 2024 Jul 16.
5
Gastroenteropancreatic neuroendocrine tumors: current perspectives and future challenges.胃肠胰神经内分泌肿瘤:当前观点与未来挑战
Cancer Metastasis Rev. 2014 Mar;33(1):343-4. doi: 10.1007/s10555-013-9469-x.
6
[Gastroenteropancreatic neuroendocrine tumor microenvironment and related therapy].[胃肠胰神经内分泌肿瘤微环境及相关治疗]
Zhonghua Wai Ke Za Zhi. 2019 Nov 1;57(11):866-871. doi: 10.3760/cma.j.issn.0529-5815.2019.11.014.
7
Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study.中国人群胃肠胰神经内分泌肿瘤的临床病理特征及预后:一项大型回顾性单中心研究
BMC Endocr Disord. 2017 Jul 13;17(1):39. doi: 10.1186/s12902-017-0190-6.
8
Epidemiological Data and Treatment of Gastroenteropancreatic Neuroendocrine Neoplasms: Insights From Tertiary Referral Hospitals in Latvia.拉脱维亚三级转诊医院对胃肠胰神经内分泌肿瘤的流行病学数据及治疗见解
World J Surg. 2020 Feb;44(2):585-593. doi: 10.1007/s00268-019-05219-0.
9
New and Emerging Treatment Options for Gastroenteropancreatic Neuroendocrine Tumors.胃肠胰神经内分泌肿瘤的新型及新兴治疗方案
Clin Adv Hematol Oncol. 2015 May;13(5 Suppl 5):1-18; quiz 1 p following 18.
10
Gastroenteropancreatic neuroendocrine neoplasms: epidemiology, genetics, and treatment.胃肠胰神经内分泌肿瘤:流行病学、遗传学和治疗。
Front Endocrinol (Lausanne). 2024 Sep 30;15:1424839. doi: 10.3389/fendo.2024.1424839. eCollection 2024.

引用本文的文献

1
Association of integrated biomarkers and progression-free survival prediction in patients with gastroenteropancreatic neuroendocrine tumors undergoing [177Lu]Lu-DOTA-TATE therapy.接受[177Lu]Lu-DOTA-TATE治疗的胃肠胰神经内分泌肿瘤患者中综合生物标志物与无进展生存预测的关联
Theranostics. 2025 May 25;15(13):6444-6453. doi: 10.7150/thno.112588. eCollection 2025.
2
Risk factors for neuroendocrine neoplasms: protocol for a case-control study based on a record linkage of registry and claims data.神经内分泌肿瘤的危险因素:基于登记处和索赔数据记录链接的病例对照研究方案
BMJ Open. 2025 May 23;15(5):e096273. doi: 10.1136/bmjopen-2024-096273.
3
Resistant gastroenteropancreatic neuroendocrine tumors: a definition and guideline to medical and surgical management.
耐药性胃肠胰神经内分泌肿瘤:医学及手术管理的定义与指南
Proc (Bayl Univ Med Cent). 2023 Dec 20;37(1):104-110. doi: 10.1080/08998280.2023.2284039. eCollection 2024.
4
Site-specific trends in gastroenteropancreatic neuroendocrine neoplasms in Bavaria, Germany.德国巴伐利亚胃肠胰神经内分泌肿瘤的部位特异性趋势。
Cancer Med. 2023 Oct;12(19):19949-19958. doi: 10.1002/cam4.6510. Epub 2023 Sep 22.
5
Gastroenteropancreatic neuroendocrine neoplasms: A clinical snapshot.胃肠胰神经内分泌肿瘤:临床概述。
World J Gastrointest Surg. 2021 Mar 27;13(3):231-255. doi: 10.4240/wjgs.v13.i3.231.